Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 2014 Jul 9;177(2):555. doi: 10.1111/cei.12398

Retraction: ‘CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice’ by J. Li, K. Zhang, P. Ye, S. Wang and J. Xia

PMCID: PMC4226607  PMID: 25165793

The above article in Clinical and Experimental Immunology, published online on 26 May 2009 in Wiley Online Library (http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2249.2009.03982.x/abstract) and in Volume 157, Issue 3, pages 437-445, has been retracted by agreement between the authors, the journal Editor-in-Chief, Professor Mark Peakman, and John Wiley and Sons Ltd. This is following an investigation by the authors’ institute (Department of Cardiovascular Surgery, Union Hospital, Tongji Medical College, Huazhong Science and Technology University, Wuhan 430022, China) into misrepresentations within figures and a loss of the original data, which invalidates the results presented.

Reference

  1. Li J, Zhang K, Ye P, Wang S, Xia J. CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice. Clinical & Experimental Immunology. 2009;157:437–445. doi: 10.1111/j.1365-2249.2009.03982.x. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES